Proteomics analysis of the p.G849D variant in neurexin 2 alpha may reveal insight into Parkinson’s disease pathobiology
| dc.contributor.author | Cloete, R | |
| dc.date.accessioned | 2023-03-22T09:49:00Z | |
| dc.date.available | 2023-03-22T09:49:00Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | Parkinson’s disease (PD), the fastest-growing neurological disorder globally, has a complex etiology. A previous study by our group identified the p.G849D variant in neurexin 2 (NRXN2), encoding the synaptic protein, NRXN2α, as a possible causal variant of PD. Therefore, we aimed to perform functional studies using proteomics in an attempt to understand the biological pathways affected by the variant. We hypothesized that this may reveal insight into the pathobiology of PD. Wild-type and mutant NRXN2α plasmids were transfected into SH-SY5Y cells. Thereafter, total protein was extracted and prepared for mass spectrometry using a Thermo Scientific Fusion mass spectrometer equipped with a Nanospray Flex ionization source. The data were then interrogated against the UniProt H. sapiens database and afterward, pathway and enrichment analyses were performed using in silico tools. Overexpression of the wild-type protein led to the enrichment of proteins involved in neurodegenerative diseases, while overexpression of the mutant protein led to the decline of proteins involved in ribosomal functioning | en_US |
| dc.identifier.citation | Cuttler, K., Fortuin, S., Müller-Nedebock, A.C., Vlok, M., Cloete, R., Bardien, S., 2022. Proteomics analysis of the p.G849D variant in neurexin 2 alpha may reveal insight into Parkinson’s disease pathobiology. Frontiers in Aging Neuroscience.14, 1002777. https://doi.org/10.3389/fnagi.2022.1002777 | en_US |
| dc.identifier.issn | 1663-4365 | |
| dc.identifier.uri | http://hdl.handle.net/10566/8642 | |
| dc.language.iso | en | en_US |
| dc.publisher | Frontiers | en_US |
| dc.subject | parkinson’s disease | en_US |
| dc.subject | proteomics | en_US |
| dc.subject | mass spectrometry | en_US |
| dc.subject | synaptic translation | en_US |
| dc.subject | mitochondrial dysfunction | en_US |
| dc.title | Proteomics analysis of the p.G849D variant in neurexin 2 alpha may reveal insight into Parkinson’s disease pathobiology | en_US |
| dc.type | Article | en_US |